Show 15 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author="Nagy, Zsolt" or (type exact bookEditor and editor="Nagy, Zsolt") Add to list Conference Paper C3 Characterization of the long-term efficacy and safety of duvelisib monotherapy in patients with relapsed/refractory CLL/SLL on treatment for > 2 years across 4 clinical studies Ian W Flinn, Marco Montillo, Zsolt Nagy, Zoltan Gasztonyi, Matthew S Davids, Klaus Geissler, Jose J Rifon Roca, Leanne Berkhan, Fritz Offner (UGent) , NgocDiep Le, et al. (2018) BLOOD. 132(suppl. 1). Add to list Journal Article A1 The phase 3 DUO trial : duvelisib vs ofatumumab in relapsed and refractory CLL/SLL Ian W Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Arpad Illes, Gabriel Etienne, Julio Delgado, Bryone J Kuss, Constantine S Tam, Zoltan Gasztonyi, et al. (2018) BLOOD. 132(23). p.2446-2455 Add to list Conference Paper C3 Results from the phase 3 DUOTM trial : a randomized comparison of duvelisib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma Ian W Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Arpad Illes, Gabriel Etienne, Julio Delgado, Bryone Jean Kuss, Constantine S Tam, Zoltan Gasztonyi, et al. (2017) BLOOD. 130(suppl. 1).